Aflunov (egg-derived H5N1 vaccine with MF59) / CSL Behring - LARVOL DELTA

The Road to Readiness: Commentary on the Journey of a Zoonotic H5 Influenza Vaccine Strain Update. (PubMed, Vaccines (Basel)) - P2 | "To facilitate regulatory approval, the licence of an existing zoonotic vaccine, Aflunov (A/turkey/Turkey/01/2005)-a pre-pandemic monovalent A/H5N1 adjuvanted with MF59 and manufactured using the egg-based platform-was duplicated, with the plan to submit a variation to the duplicate licence for the strain update. In terms of procurement and logistics, early consultation between the European Commission and EU member states resulted in the award of a Framework Contract for the initial supply of 665,000 doses to 15 states. Learnings from the development of this vaccine may help to improve pandemic readiness in the future."

Journal • Review • Infectious Disease • Influenza • Respiratory Diseases